vs

Side-by-side financial comparison of Neuronetics, Inc. (STIM) and USCB FINANCIAL HOLDINGS, INC. (USCB). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $22.2M, roughly 1.9× USCB FINANCIAL HOLDINGS, INC.). USCB FINANCIAL HOLDINGS, INC. runs the higher net margin — 6.1% vs -17.2%, a 23.4% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 14.7%). USCB FINANCIAL HOLDINGS, INC. produced more free cash flow last quarter ($42.5M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 12.3%).

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

USCB Financial Holdings, Inc. is a U.S.-headquartered bank holding company that offers comprehensive retail and commercial banking services, including deposit products, personal and business loans, wealth management, and digital banking tools. It primarily serves individual consumers, small and medium-sized enterprises, and local corporate clients across its operating regions in the United States, prioritizing personalized customer experiences and community-oriented financial services.

STIM vs USCB — Head-to-Head

Bigger by revenue
STIM
STIM
1.9× larger
STIM
$41.8M
$22.2M
USCB
Growing faster (revenue YoY)
STIM
STIM
+71.0% gap
STIM
85.7%
14.7%
USCB
Higher net margin
USCB
USCB
23.4% more per $
USCB
6.1%
-17.2%
STIM
More free cash flow
USCB
USCB
$41.8M more FCF
USCB
$42.5M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
12.3%
USCB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
STIM
STIM
USCB
USCB
Revenue
$41.8M
$22.2M
Net Profit
$-7.2M
$1.4M
Gross Margin
52.0%
Operating Margin
-12.1%
14.7%
Net Margin
-17.2%
6.1%
Revenue YoY
85.7%
14.7%
Net Profit YoY
43.2%
-80.3%
EPS (diluted)
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STIM
STIM
USCB
USCB
Q4 25
$41.8M
$22.2M
Q3 25
$37.3M
$25.0M
Q2 25
$38.1M
$24.4M
Q1 25
$32.0M
$22.8M
Q4 24
$22.5M
$23.0M
Q3 24
$18.5M
$21.5M
Q2 24
$16.4M
$20.5M
Q1 24
$17.4M
$17.6M
Net Profit
STIM
STIM
USCB
USCB
Q4 25
$-7.2M
$1.4M
Q3 25
$-9.0M
$8.9M
Q2 25
$-10.1M
$8.1M
Q1 25
$-12.7M
$7.7M
Q4 24
$-12.7M
$6.9M
Q3 24
$-13.3M
$6.9M
Q2 24
$-9.8M
$6.2M
Q1 24
$-7.9M
$4.6M
Gross Margin
STIM
STIM
USCB
USCB
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
STIM
STIM
USCB
USCB
Q4 25
-12.1%
14.7%
Q3 25
-19.6%
47.3%
Q2 25
-21.1%
44.0%
Q1 25
-34.4%
44.2%
Q4 24
-51.0%
39.6%
Q3 24
-41.7%
42.5%
Q2 24
-51.7%
39.8%
Q1 24
-39.4%
34.3%
Net Margin
STIM
STIM
USCB
USCB
Q4 25
-17.2%
6.1%
Q3 25
-24.3%
35.8%
Q2 25
-26.6%
33.4%
Q1 25
-39.6%
33.5%
Q4 24
-56.4%
30.0%
Q3 24
-72.0%
32.3%
Q2 24
-59.8%
30.3%
Q1 24
-45.2%
26.2%
EPS (diluted)
STIM
STIM
USCB
USCB
Q4 25
$-0.10
Q3 25
$-0.13
$0.45
Q2 25
$-0.15
Q1 25
$-0.21
Q4 24
$-0.34
Q3 24
$-0.44
$0.35
Q2 24
$-0.33
Q1 24
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STIM
STIM
USCB
USCB
Cash + ST InvestmentsLiquidity on hand
$28.1M
$38.5M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$22.4M
$217.2M
Total Assets
$141.6M
$2.8B
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STIM
STIM
USCB
USCB
Q4 25
$28.1M
$38.5M
Q3 25
$28.0M
$56.8M
Q2 25
$11.0M
$54.8M
Q1 25
$20.2M
$98.0M
Q4 24
$18.5M
$77.0M
Q3 24
$20.9M
$38.5M
Q2 24
$42.6M
$77.3M
Q1 24
$47.7M
$126.5M
Total Debt
STIM
STIM
USCB
USCB
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
STIM
STIM
USCB
USCB
Q4 25
$22.4M
$217.2M
Q3 25
$27.4M
$209.1M
Q2 25
$27.1M
$231.6M
Q1 25
$35.5M
$225.1M
Q4 24
$27.7M
$215.4M
Q3 24
$9.4M
$213.9M
Q2 24
$19.4M
$201.0M
Q1 24
$27.7M
$195.0M
Total Assets
STIM
STIM
USCB
USCB
Q4 25
$141.6M
$2.8B
Q3 25
$145.5M
$2.8B
Q2 25
$134.7M
$2.7B
Q1 25
$142.0M
$2.7B
Q4 24
$140.9M
$2.6B
Q3 24
$2.5B
Q2 24
$96.8M
$2.5B
Q1 24
$103.8M
$2.5B
Debt / Equity
STIM
STIM
USCB
USCB
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STIM
STIM
USCB
USCB
Operating Cash FlowLast quarter
$908.0K
$42.8M
Free Cash FlowOCF − Capex
$692.0K
$42.5M
FCF MarginFCF / Revenue
1.7%
191.4%
Capex IntensityCapex / Revenue
0.5%
1.4%
Cash ConversionOCF / Net Profit
31.40×
TTM Free Cash FlowTrailing 4 quarters
$-21.2M
$95.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STIM
STIM
USCB
USCB
Q4 25
$908.0K
$42.8M
Q3 25
$-785.0K
$20.1M
Q2 25
$-3.5M
$18.0M
Q1 25
$-17.0M
$14.6M
Q4 24
$-8.6M
$34.8M
Q3 24
$-5.4M
$11.3M
Q2 24
$-5.0M
$18.3M
Q1 24
$-12.0M
$8.1M
Free Cash Flow
STIM
STIM
USCB
USCB
Q4 25
$692.0K
$42.5M
Q3 25
$-899.0K
$20.0M
Q2 25
$-3.8M
$18.0M
Q1 25
$-17.2M
$14.6M
Q4 24
$-8.7M
$34.5M
Q3 24
$-5.8M
$11.2M
Q2 24
$-5.6M
$18.2M
Q1 24
$-12.4M
$8.0M
FCF Margin
STIM
STIM
USCB
USCB
Q4 25
1.7%
191.4%
Q3 25
-2.4%
80.3%
Q2 25
-9.9%
73.7%
Q1 25
-53.8%
63.9%
Q4 24
-38.6%
150.2%
Q3 24
-31.3%
52.2%
Q2 24
-34.0%
88.8%
Q1 24
-71.1%
45.4%
Capex Intensity
STIM
STIM
USCB
USCB
Q4 25
0.5%
1.4%
Q3 25
0.3%
0.5%
Q2 25
0.7%
0.2%
Q1 25
0.7%
0.2%
Q4 24
0.4%
1.4%
Q3 24
2.1%
0.4%
Q2 24
3.7%
0.4%
Q1 24
2.2%
0.5%
Cash Conversion
STIM
STIM
USCB
USCB
Q4 25
31.40×
Q3 25
2.25×
Q2 25
2.22×
Q1 25
1.91×
Q4 24
5.05×
Q3 24
1.63×
Q2 24
2.95×
Q1 24
1.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons